237 results on '"Borrego R"'
Search Results
52. A bilateral congenital pits of the optic nerve head. A case report
- Author
-
VILLAFRUELA, I, primary, CLARIANA, A, additional, RIVAS, O, additional, FERNADEZ, A, additional, BORREGO, R, additional, COLAS, T, additional, ARTEAGA, P, additional, and CACHO, L, additional
- Published
- 2009
- Full Text
- View/download PDF
53. P.2.c.001 Antidepressant treatment in a primary mental health center – tolerability and clinical improvement – patients opinion
- Author
-
Falces, A., primary, Conesa, C., additional, Borrego, R., additional, Bel, T., additional, and Corominas, A., additional
- Published
- 2008
- Full Text
- View/download PDF
54. P.18. Rabdomiólisis en lactante. A propósito de un caso
- Author
-
Navarro, M.J., primary, Zambrano, E., additional, Cazorla, M.R., additional, Arjona, D., additional, Sánchez-Redondo, M.D., additional, Tapia, R., additional, Borrego, R., additional, and Alonso, J.A., additional
- Published
- 2007
- Full Text
- View/download PDF
55. EARLY TRANSPYLORIC ENTERAL NUTRITION IN CRITICALLY ILL CHILDREN
- Author
-
S??nchez, C, primary, L??pez-Herce, J, additional, Borrego, R, additional, and Menc??a, S, additional
- Published
- 2007
- Full Text
- View/download PDF
56. Efficacy and safety of a phyto-SERM as an alternative to hormone therapy.
- Author
-
Sánchez-Borrego, R., Navarro, M. C., Llaneza, P., Hormigo, A., Duran, M., and Mendoza, N.
- Subjects
- *
SELECTIVE estrogen receptor modulators , *HORMONE therapy , *ESTROGEN receptors , *POSTMENOPAUSE , *VASOMOTOR conditioning , *PHYTOESTROGENS , *OSTEOPOROSIS prevention - Abstract
In this review, we analyze the efficacy and safety of DT56a in the treatment of postmenopausal symptoms. Similar to all selective estrogen receptor modulators (SERMs), DT56a demonstrates dual agonistic and antagonistic effects due to the synergy between its components. DT56a is referred to as a plant-origin SERM (phyto-SERM) and, for this reason, its therapeutic capacity in postmenopausal women differs from other phytoestrogens used independently. Although interesting data on relief of vasomotor symptoms have been reported for DT56a, further clinical studies with a greater number of cases and a longer period of study are required to correctly identify its indications for use as an alternative to hormone therapy, especially in preventing osteoporosis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
57. The importance of preventive health care in post-menopausal women
- Author
-
Palacios, S., primary, Borrego, R. Sanchez, additional, and Forteza, A., additional
- Published
- 2005
- Full Text
- View/download PDF
58. Posicionamiento sobre la fitoterapia en la menopausia. Barcelona, 2004
- Author
-
Durán, M., primary, Allué, J., additional, Beltrán, E., additional, Bris, J.M., additional, Calaf, J., additional, Cancelo, M.J., additional, Cano, A., additional, Nishishinya, B., additional, Ribes, M., additional, Sánchez-Borrego, R., additional, and Palacios, S., additional
- Published
- 2005
- Full Text
- View/download PDF
59. Documento de Consenso SEGO-AEEM sobre terapia hormonal sustitutiva
- Author
-
Cano, A., primary, Palacios, S., additional, Calaf, J., additional, Parrilla, J.L., additional, Dueñas, J.L., additional, Lete, I., additional, Cancelo, M.J., additional, and Sánchez-Borrego, R., additional
- Published
- 2005
- Full Text
- View/download PDF
60. EXTUBATION AFTER SPONTANEOUS BREATHING TRIAL WITH AUTOMATIC TUBE COMPENSATION VERSUS PRESSURE SUPORT.
- Author
-
Arjona, D., Santos, P., Perez, M., Herrera, M., Borrego, R., Torralba, M., Ramos, N., Martin, S., Martin, B., Sanchez, L., Gutierrez, M., Garreta, H., Losada, B., Villarino, R., Garcia, A., and Ortiz, I.
- Published
- 2022
61. PIH48 - Structural Validity of a 14-Item Abridged Version of the Menopause Cervantes Health-Related-Quality-Of-Life Scale
- Author
-
Coronado, P., Sánchez-Borrego, R., Palacios, S., Ruiz, M.A., and Rejas, J.
- Published
- 2013
- Full Text
- View/download PDF
62. Contraception: Ethinyl oestradiol plus dl-norgestrel or levonorgestrel in the Yuzpe method for post-coital contraception: results of an observational study
- Author
-
Sanchez-Borrego, R., primary and Balasch, J., additional
- Published
- 1996
- Full Text
- View/download PDF
63. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
- Author
-
Baró F, Cano A, Sánchez Borrego R, Ferrer J, González Rodríguez SP, Neyro JL, Rodriguez Bueno E, Sancho C, Inaraja V, Fernández C, Corral C, and FROSPE Study Group
- Published
- 2012
- Full Text
- View/download PDF
64. La 'marca' de la adopción
- Author
-
Borrego, R.
- Published
- 1996
65. Ethinyl oestradiol plus dl-norgestrel or levonorgestrel in the Yuzpe method for post-coital contraception: results of an observational study.
- Author
-
Sánchez-Borrego, R and Balasch, J
- Subjects
EMERGENCY contraceptives ,MENSTRUATION ,NAUSEA ,SYNTHETIC progestagens ,STEROIDS ,VOMITING ,LEVONORGESTREL - Abstract
This observational study compares the efficacy and incidence of side-effects between dl-norgestrel (2 mg) and levonorgestrel (1 mg) associated with ethinyl oestradiol (200 micrograms) given in two doses 12 h apart for emergency post-coital contraception. A total of 117 consecutive women were given dl-norgestrel in combination with the oestrogen (dl-norgestrel group) while 423 consecutive subjects received the combination ethinyl oestradiol/levonorgestrel (levonorgestrel group). Overall, four (0.8%) pregnancies occurred in the 540 treated women, one (0.9%) in the dl-norgestrel group and three (0.7%) in the levonorgestrel group. In addition to this similar high contraceptive efficacy between both study groups, women in the levonorgestrel group had a significantly lower incidence of side-effects (23.5%) and better timing of the next menstruation after treatment (75% had bleeding on time) than those in the dl-norgestrel group (corresponding figures were 50.5 and 62.6% respectively). It is concluded that levonorgestrel should be used in preference to dl-norgestrel for post-coital contraception in the Yuzpe regimen. [ABSTRACT FROM AUTHOR]
- Published
- 1996
- Full Text
- View/download PDF
66. Severe ischemia of the lower limb and of the intestine associated with systemic vasoconstrictor therapy and femoral arterial catheterization.
- Author
-
Borrego R, López-Herce J, Mencía S, Carrillo A, Sancho L, and Bustinza A
- Published
- 2006
- Full Text
- View/download PDF
67. Saúde e estilos de vida no concelho de Loures (2009)
- Author
-
David Tavares, Antunes, C., Coelho, A., Flores, B., Fortes, C., Medeiros, Nuno, and Borrego, R.
68. Numerical simulation and data visualization of a wildland fire in the Ebro basin
- Author
-
Asensio, M. I., Ferragut, L., Borrego, R., Serón, F. J., Juan Magallón, and Gutiérrez, D.
69. Role of ospemifene in the treatment of vulvar and vaginal atrophy in postmenopausal woman,Papel de ospemifeno en el tratamiento de la atrofia vulvovaginal en la mujer posmenopáusica
- Author
-
Cancelo Hidalgo, M. J., Camil Castelo-Branco, Sánchez Borrego, R., Llaneza Coto, P., Palacios Gil-Antuñano, S., Molero Rodríguez, F., Caballero Gómez, I., and Gallego Luis, R.
70. Nonhormonal therapies in menopause,Terapias no hormonales en la menopausia
- Author
-
Santiago Palacios and Sánchez Borrego, R.
71. A 2.3-dB NF CMOS low voltage LNA optimized for medical applications at 600MHz
- Author
-
Borrego, R., João Oliveira, and Goes, J.
72. "Sempre a Bombear": intervenção multidisciplinar de promoção da saúde em meio escolar.
- Author
-
Almeida, A., Belo, J., Borrego, R., Leal, E., Sousa, J., Azevedo, J., Camarinha, C., Canilho, J., Carrapeta, S., Centeno, J., Fernandes, S., Ferreira, M., Gomes, I., Gonçalves, A., Melo, I., Santos, F., Silva, A., and Torrinha, C.
- Published
- 2011
73. Projecto SEMPRE A BOMBEAR: promoção da saúde e educação alimentar num âmbito multidisciplinar.
- Author
-
Fernandes, S., Borrego, R., Sousa, J., and Mendes, L.
- Published
- 2011
74. PIPA - Piloto 2007-2011: uma estratégia de educação alimentar.
- Author
-
Fernandes, S., Borrego, R., Sousa, J., and Mendes, L.
- Published
- 2011
75. Early transpyloric enteral nutrition in critically ill children.
- Author
-
Sánchez C, López-Herce S, Borrego R, and Mencía S
- Published
- 2007
76. Obesity and menopause.
- Author
-
Palacios S, Chedraui P, Sánchez-Borrego R, Coronado P, and Nappi RE
- Subjects
- Female, Humans, Women's Health, Hot Flashes etiology, Obesity complications, Estrogen Replacement Therapy adverse effects, Quality of Life, Menopause
- Abstract
Obesity is not a choice or a result of lack of willpower, but a multifactorial, chronic, progressive, and relapsing disease. During menopause, hormonal and body composition changes lead to greater visceral adiposity, that aggravates women's health at a cardiometabolic, mechanic and mental level. Adiposity has been identified as an important modifier of reproductive hormones. During female midlife, obesity has been associated with menstrual cycle alterations (anovulatory cycles ending with abnormal bleedings), menopausal symptoms including hot flashes, poor quality of sleep, aches and joint pain, genitourinary symptoms, and reduced quality of life. However, the relationships between weight, the menopausal process, aging, and hormone levels remain poorly understood. Women with obesity have an increased risk of thromboembolic disease when using menopause hormone therapy (MHT), and it is probably the main medical condition to prescribe or not MHT. However, this risk depends on the route and type of MHT. The use of estrogen-only or combined transdermal MHT does not increase the risk of a thrombotic event in women with obesity.
- Published
- 2024
- Full Text
- View/download PDF
77. Rural residence and health-related quality of life in a sample of Spain perimenopausal women.
- Author
-
Llaneza-Suarez C, Garcia-Portilla P, Rodriguez-Vijande B, Carriles J, Sánchez-Prieto M, Coronado Martín PJ, Llaneza Coto ÁP, and Sánchez-Borrego R
- Subjects
- Female, Humans, Cross-Sectional Studies, Spain epidemiology, Rural Population, Surveys and Questionnaires, Perimenopause, Quality of Life
- Abstract
Background: The prevalence and severity of perimenopausal symptoms are typically associated with multiple factors, including demographic characteristics. The sociodemographic characteristics of women living in rural areas differ from those residing in urban areas, and it has been suggested that these differences could potentially influence the prevalence of symptoms experienced during perimenopause., Objectives: To evaluate if perimenopausal women living in Spanish rural areas have a higher prevalence of perimenopausal symptoms and assess their influence on health-related quality of life., Methods: A cross-sectional study was conducted in a sample of 270 perimenopausal women residing in rural and urban areas. The participants completed the Cervantes Scale Short Version and Beck Depression Inventory 2., Results: Perimenopausal women in rural areas reported a higher incidence of perimenopausal symptoms and a lower perception of health-related quality of life compared to those in urban areas, as evidenced by higher scores on the total Cervantes Scale Short Version scale (33.2 (±16.2) vs. 26.4 (±18.1), p = .001). No differences in the Beck Depression Inventory 2 score were detected., Conclusions: Perimenopausal women residing in rural areas of Spain reported a higher prevalence of perimenopausal symptoms and experienced a poorer Health-Related Quality of Life compared to those living in urban areas of Spain.
- Published
- 2024
- Full Text
- View/download PDF
78. Management of obesity in menopause.
- Author
-
Palacios S, Chedraui P, Sanchez-Borrego R, Coronado P, Simoncini T, Schauding K, Hillard T, and Nappi RE
- Subjects
- Humans, Female, Quality of Life, Weight Loss, Middle Aged, Gynecology, Life Style, Menopause physiology, Obesity therapy, Bariatric Surgery
- Abstract
The increasing prevalence of obesity imposes significant health challenges, particularly in women undergoing menopause. Effective obesity management is essential to mitigate associated comorbidities and improve quality of life. The pillars of obesity treatment encompass lifestyle modifications, pharmacotherapy and surgical interventions. Pharmacotherapy may be considered for women who do not achieve adequate weight loss through lifestyle changes alone and have obesity or overweight with risk factors. Bariatric surgery is reserved for individuals with severe obesity or those with obesity-related complications. During menopause, hormonal changes contribute to weight gain and fat redistribution, complicating obesity management. Tailored treatment strategies are necessary to address the unique challenges faced by this population. The role of physicians and gynecologists is pivotal in the multidisciplinary approach to obesity management during menopause. Gynecologists are often the primary health-care providers for menopausal women and are in a unique position to offer guidance on weight management. They can provide personalized counseling, coordinate with nutritionists, endocrinologists and bariatric specialists, and monitor the effects of obesity and its treatment on reproductive health. By integrating obesity management into routine gynecological care, gynecologists can significantly impact the overall health and well-being of menopausal women.
- Published
- 2024
- Full Text
- View/download PDF
79. Testicular Torsion as a Complication Following Preperitoneal Packing for Pelvic Fractures in a Motorcycle Accident: A Case Report.
- Author
-
Caussat T, Kong H, Macknofsky B, Mann A, Rueda M, and Borrego R
- Abstract
This case report highlights a rare but significant complication of blunt trauma requiring preperitoneal packing and illustrates the intricate relationship between trauma surgery and urological emergencies. Testicular torsion is an acute urological emergency necessitating prompt surgical intervention to salvage testicular function. While commonly associated with intrinsic factors such as the "bell-clapper" deformity, extrinsic factors such as trauma and postoperative complications can also precipitate this condition. This case underscores the complexity of diagnosing and managing testicular torsion arising after surgical interventions for pelvic fractures, a scenario sparsely documented in medical literature. We present a 27-year-old male who sustained multiple injuries, including a pelvic fracture, from a motorcycle accident and subsequently underwent preperitoneal packing for significant pelvic hemorrhage. Five days post-operation, the patient developed acute right lower quadrant and unilateral testicular pain, leading to the diagnosis of testicular torsion via Doppler ultrasonography. An emergency bilateral orchiopexy was performed, revealing a 180° torsion of the right testis. This case illustrates the need for a heightened awareness of potential genitourinary complications following trauma surgery. The pathophysiological mechanisms possibly include increased intra-abdominal pressure and altered testicular mobility due to surgical interventions. The report emphasizes the importance of multidisciplinary care in trauma settings to ensure comprehensive evaluation and management of patients, including the consideration of urological complications. Testicular torsion following preperitoneal packing for pelvic fractures represents a critical intersection between trauma surgery complications and urological emergencies, necessitating vigilant postoperative care and multidisciplinary collaboration for timely diagnosis and intervention. This case contributes to the broader understanding of postoperative complications, advocating for an integrated approach to patient care in high-energy trauma scenarios., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Caussat et al.)
- Published
- 2024
- Full Text
- View/download PDF
80. Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia.
- Author
-
Sánchez-Prieto M, Pingarrón C, Bergamaschi L, Bermúdez JC, Subiris González J, Sánchez Sánchez R, Poyo Torcal S, Gómez M, Ruiz Pérez ML, Castillo Martínez M, Peña Penedo ME, and Sánchez-Borrego R
- Subjects
- Female, Humans, Atrophy pathology, Hyaluronic Acid therapeutic use, Lubricants therapeutic use, Pain drug therapy, Prospective Studies, Vagina pathology, Water, Dyspareunia, Vaginal Diseases drug therapy, Vaginal Diseases pathology
- Abstract
Background: Vaginal dryness (VD) represents a significant concern affecting women across diverse life stages, encompassing both pre- and postmenopausal women at any age. Dyspareunia, defined by genital pain that can be experienced before, during, or after intercourse, is often associated with vaginal dryness., Aim: This study aimed to evaluate the effectiveness and safety of a water-based vaginal lubricant with hyaluronic acid to reduce sexual discomfort associated with vaginal dryness., Methods: A prospective, multicenter, uncontrolled clinical investigation was conducted over a three-month period in women aged 18 years or older experiencing pain or difficulty during sexual intercourse for whom the use of a vaginal lubricant was recommended., Results: Significant improvements were observed in the FSFI scores, indicating enhanced sexual function ( p < .001). Vaginal dryness symptoms, including irritation, dryness, itching, and dyspareunia, significantly decreased after product use ( p < .001)., Clinical Implications: This study contributes to the limited scientific knowledge on the application of lubricants in the context of symptoms associated with VD., Strengths & Limitations: In addition to the short study period, inherent limitations of the study design, and lack of placebo control, it is pertinent to acknowledge that some of the pros used in this study were not based on validated questionnaires. However, as far as we know, this study is the only one that analyzes well-being and sexual pleasure as results using a lubricant formulated with hyaluronic acid., Conclusion: This tested vaginal lubricant with hyaluronic acid has demonstrated efficacy in improving vaginal dryness and female sexual function, particularly in reducing pain and improving lubrication during sexual intercourse, and showed a favorable safety profile, with minimal and transient adverse events.
- Published
- 2024
- Full Text
- View/download PDF
81. Effect of Motor Competence and Health-Related Fitness in the Prevention of Metabolic Syndrome Risk Factors.
- Author
-
Pombo A, Cordovil R, Rodrigues LP, Moreira AC, Borrego R, Machado M, Costa V, Almeida A, Tavares AS, de Sá CC, and Luz C
- Subjects
- Child, Humans, Hand Strength, Risk Factors, Obesity, Exercise, Metabolic Syndrome
- Abstract
Purpose : In the last decades we have seen an increase in sedentary behaviors and a decrease in physical activity in children when compared to past generations. This lifestyle is commonly associated with the development of clustering risk factors that define metabolic syndrome (MetS). Knowing that motor competence (MC) development can influence lifelong physical activity habits, it is reasonable to assume that children's MC will directly link to clustered cardiometabolic health outcomes. The aim of this study was to analyze the role of MC in MetS risk factors. Methods : Seventy children with a mean age of 7.49 (SD = 1.28) years were evaluated on motor competence (MCA-Motor Competence Assessment instrument), cardiovascular fitness (PACER test), upper body strength (UBS; handgrip), and the components of MetS, hypertriglyceridemia, hypertension, abdominal obesity, low concentration of high-density lipoprotein cholesterol, and high fasting blood glucose. The composite value of MetS was calculated according to Burns et al. (2017). Multiple standard regressions were performed to explore the effect of different variables on MetS. Motor competence and health-related fitness (cardiovascular fitness and relative upper body strength) were used as independent variables (predictors) and MetS as dependent variable. Results : Overall, the results showed that motor competence ( β = -.072; p < .05) is a significant predictor and this model explained 7,1% of the variance in MetS. Conclusion: Although more studies are needed, our results indicate that MC seems to have a positive role in children's health markers.
- Published
- 2024
- Full Text
- View/download PDF
82. Compartment Syndrome Resulting From Improper Intraosseous Cannulation: A Case Report.
- Author
-
Desai KK, Mann AJ, Azar F, Lottenberg L, and Borrego R
- Abstract
Obtaining adequate vascular access is imperative for effective resuscitative, therapeutic, and diagnostic interventions. The intraosseous (IO) route is indicated when immediate vascular access is needed, and standard central or peripheral intravenous (IV) access is unattainable or would delay therapy in a critical patient. We present a rare case of improper IO line placement in the right proximal tibia of a 30-year-old female involved in a motor vehicle collision, resulting in extravasation of blood products into the surrounding tissue and development of acute compartment syndrome. Emergency Medical Services was unable to obtain IV access in a timely manner, thus a right proximal tibia 45mm IO line was placed, and a unit of whole blood was given with a high-pressure infusor in the field. At the trauma center, the patient's right lower extremity was severely tense and edematous with no palpable right lower extremity pulses and no Doppler signals. Computed tomography revealed the IO catheter extending through both the proximal and distal cortices of the right tibia. Medial and lateral fasciotomy of the right lower extremity was performed in which all four compartments of the right lower leg were released and a significant hematoma was evacuated from the superficial posterior compartment. This case highlights the importance of IO access as a life-saving intervention while also underscoring the need to educate and familiarize pre-hospital and hospital healthcare personnel in delivering IO access so as to mitigate risks and improve outcomes for critically ill patients., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Desai et al.)
- Published
- 2023
- Full Text
- View/download PDF
83. Vulvovaginal atrophy in the CRETA study: the healthcare professionals' perception.
- Author
-
Cancelo MJ, Sánchez Borrego R, Palacios S, Baquedano L, Corbacho Garza T, Fernández Aller N, García Ferreiro C, Quijano Martín JJ, and González Calvo AJ
- Subjects
- Female, Humans, Middle Aged, Atrophy drug therapy, Atrophy pathology, Delivery of Health Care, Perception, Postmenopause, Treatment Adherence and Compliance, Tamoxifen therapeutic use, Vagina pathology, Vaginal Diseases drug therapy, Vaginal Diseases pathology, Vulva pathology, Gynecologists
- Abstract
Objectives: The objective is to assess the perception of gynecologists regarding patients' adherence to vulvovaginal atrophy (VVA) treatments, to evaluate the gynecologists' opinions on what their patients think about treatment adherence, and to compare the gynecologists' opinions with the patients' own perceptions within the CRETA study., Methods: Spanish gynecologists who participated in the CRETA study were asked to fill out an online 41-item questionnaire to evaluate their views on VVA management., Results: From 29 centers across Spain, 44 gynecologists completed the survey. Their mean age was 47.2 years old, two-thirds of them were women, and the average professional experience was over 20 years. According to the gynecologists, the therapy most frequently used by VVA-diagnosed women was vaginal moisturizers (45.5%), followed by local estrogen therapy (36.4%) and ospemifene (18.2%). Nevertheless, ospemifene was viewed as the therapeutic option with the most efficacy, easiest route of administration, shorter time to symptom improvement, lower percentage of dropouts, and higher treatment adherence., Conclusions: Spanish gynecologists are in general agreement with their patients regarding VVA treatment preferences and the main issues for adherence and effectiveness. However, there is an opportunity for doctor-patient communication improvement. Among the three therapeutic options evaluated, ospemifene is regarded as offering some competitive advantages.
- Published
- 2023
- Full Text
- View/download PDF
84. In Vitro Studies of Endophytic Bacteria Isolated from Ginger ( Zingiber officinale ) as Potential Plant-Growth-Promoting and Biocontrol Agents against Botrytis cinerea and Colletotrichum acutatum .
- Author
-
Bódalo A, Borrego R, Garrido C, Bolivar-Anillo HJ, Cantoral JM, Vela-Delgado MD, González-Rodríguez VE, and Carbú M
- Abstract
Agriculture currently confronts a multitude of challenges arising from the excessive utilization of chemical pesticides and the proliferation of phytopathogenic fungi strains that exhibit resistance to commonly employed active compounds in the field. Botrytis cinerea and Colletotrichum acutatum are phytopathogenic fungi that inflict substantial economic losses within agriculture and food due to their high impacts on crops both pre- and post-harvest. Furthermore, the emergence of fungal strains that are resistant to commercial fungicides has exacerbated this problem. To explore more environmentally sustainable alternatives for the control of these pathogens, an investigation into the endophytic bacteria associated with ginger ( Zingiber officinale Rosc.) was conducted. The primary focus of this study involved evaluating their inhibitory efficacy against the fungi and assessing their potential for promoting plant growth. The endophytic bacteria genera Lelliottia , Lysinibacillus , Kocuria , Agrococcus , Acinetobacter , Agrobacterium , Zymobacter , and Mycolicibacterium were identified. All isolates showed remarkable in vitro antagonistic ability against B. cinerea (>94%) and C. acutatum (>74%). Notably, the Lelliottia amnigena J29 strain exhibited a notable proficiency in producing extracellular enzymes and indole compounds (IAA), solubilizing phosphate and potassium, and forming biofilm. Furthermore, the Lysinibacillus capsici J26, Agrococcus citreus J28, and Mycolicibacterium sp. J5 strains displayed the capacity for atmospheric nitrogen fixation and siderophore production. These findings underscore the agricultural and biotechnological potential of endophytic bacteria derived from ginger plants and suggest the feasibility of developing alternative approaches to manage these two phytopathogenic fungi.
- Published
- 2023
- Full Text
- View/download PDF
85. Ultramassive transfusion and adjunctive therapies in a case of blood bank depletion.
- Author
-
Jackson M, Berman S, Rueda M, Borrego R, Lottenberg L, and Azar F
- Abstract
Background: We present the case of a patient who presents with a high velocity thoracoabdominal gunshot wound requiring ultramassive transfusion who exhausted the county blood bank requiring adjunctive therapies to balanced blood product transfusion while additional blood products could be obtained., Summary: Thoracoabdominal gunshot wounds carry a high mortality of 14-37 % because of the risk to produce cardiopulmonary, solid organ as well as major vascular injuries (Mandal and Oparah (1989) [1]). Ultramassive transfusion (>20 units of blood product transfusion) also carries high morbidity and mortality and management has generally centered on balanced transfusion (Matthay et al. (2021) [2])., Conclusion: Balanced blood product transfusion reduces mortality for patients requiring ultramassive transfusion but when this is not possible utilization of adjuncts to blood products may temporize resuscitation until additional blood products can be obtained., Competing Interests: All authors have reviewed the manuscript in its entirety and declare that they have no significant financial conflicts of interest. The order of authorship has been reviewed and approved by all authors. Florida Atlantic University has provided funds for publication of this manuscript., (© 2023 The Authors. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
86. Brachial Artery Injury Resulting From a Dog Bite in a Pediatric Patient: A Case Report.
- Author
-
Meknarit S, Mann AJ, Azar F, and Borrego R
- Abstract
Pediatric trauma surgeons frequently encounter severe injuries from animal bites, with dog bites being especially prevalent in children, often leading to facial injuries. This paper details the case of a six-year-old male who suffered a dog bite resulting in a rare proximal right brachial artery injury. The bite caused deep lacerations and avulsion injuries, prompting admission to the trauma center, where nonpalpable right radial and ulnar pulses and arm weakness were observed. Surgical intervention, including wound exploration and brachial artery repair using a saphenous vein graft, successfully restored vascular perfusion. This case underscores the urgency of addressing pediatric dog bite injuries through timely exploration, thorough irrigation, and antibiotic prophylaxis, while also highlighting the need for further research on preventive education and clinical guidelines for assessing vascular injuries in such cases., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Meknarit et al.)
- Published
- 2023
- Full Text
- View/download PDF
87. Persistent pseudoaneurysm after non-operative management of a Grade 4 liver injury.
- Author
-
Mann AJ, Rueda M, Azar F, Ramseyer M, Lottenberg L, and Borrego R
- Abstract
A hepatic pseudoaneurysm (HPA) after blunt or penetrating liver injury is an unusual but potentially lethal complication that can develop from an injured hepatic artery branch [1-5]. Endovascular intervention with coil embolization to treat HPA is a safe and effective method and has become the standard first-line treatment, with a success rate achieving 70-100 % [13,14,15]. Infrequently the pseudoaneurysm is fed by collateral vessels and endovascular intervention may be unsuccessful. Other minimally invasive treatment options that can be considered include image guided percutaneous thrombin injection, endovascular placement of covered stents and injection of liquid agents such as fibrin glue [10,11]. We present a case of a young female who developed a post-traumatic persistent hepatic pseudoaneurysm requiring a total of nine interventions, including six endovascular interventions with angiography, three endoscopic procedures for bleeding, one percutaneous injection, and two re-admissions to the hospital. Although she avoided initial operative management, her three-month hospital course can be considered a failure of conservative management of blunt hepatic trauma due to the accrued health care costs and resources. The literature on the management of persistent pseudoaneurysm is limited. The decision to treat a persistent HPA that are found incidentally and stable in size needs further investigation., Competing Interests: None., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
88. Assessment of Food and Cooking Skills: Validation of a Portuguese Version of a Tool and Characterisation of Food and Cooking Skills in Young Adults.
- Author
-
Costa V, Borrego R, Mateus C, Carolino E, and Viegas C
- Abstract
Introduction: Food and cooking skills (FCSks) are defined as a complex, interrelated, and person-centred set of skills, necessary to provide and prepare safe, nutritious, and culturally acceptable meals for all members of the household. Recent studies have associated higher FCSk with healthier eating habits and better health. This study aimed to validate a Portuguese version of a tool to assess and describe FCSk in young adults., Methods: A cross-sectional study used an online anonymous questionnaire that was disseminated to students from three Portuguese Higher Education Institutes. The questionnaire validation included Cronbach alpha and confirmatory factor analysis (CFA). The Mann-Whitney test was used for evaluating sample differences and Pearson correlation for association among variables., Results: Internal consistency reliability was 0.89 for cooking skills (CSks) and 0.87 for food skills (FSks). A moderate positive correlation was found between CSks and FSks confidence ( r = 0.658, p < 0.01). CFA presented a good adjustment model for most of the fit indices, indicating the adequacy of the questionnaire. The CSks score was 74.1 ± 21.2 (moderate) and the food Skills was 94.2 ± 20.8 (high). Cook pulses, steaming food, and planning meals ahead scored the lowest value, while boiling or simmering food, chopping, peeling vegetables, and reading the best-before date scored the highest value. No difference was found among sex ( p
CSk = 0.576; pFSk = 0.158), age ( pCSk = 0.566; pFSk = 0.130), body mass index classes ( pCSk = 0.903; pFSk = 0.320), or course ( pCSk = 0.169; pFSk = 0.126). The greatest interest in gastronomy and frequency of meal preparation is associated with higher FCSk ( p < 0.05)., Conclusion: This research validated a Portuguese version of a tool to assess FCSk among young adults. Internal consistency reliability was adequate. Confirmatory factor analysis returned good psychometric properties for the questionnaire. Authors identified lower FCSk competencies in cooking pulses and vegetables, which are healthy and sustainable foods. This may compromise the adoption of healthy eating behaviours, so promoting FCSk in young adults may pose a strategy for nutrition and public health in reducing diet-related diseases. This tool may be used to identify opportunities for intervention in public health nutrition., Competing Interests: The authors have no conflicts of interest to declare., (© 2023 The Author(s). Published by S. Karger AG, Basel on behalf of NOVA National School of Public Health.)- Published
- 2023
- Full Text
- View/download PDF
89. Chronic vulvar fissure: approach with cross-linked hyaluronic acid.
- Author
-
González-Isaza P, Sánchez-Prieto M, and Sánchez-Borrego R
- Subjects
- Female, Humans, Vagina, Injections, Hyaluronic Acid, Vulva
- Abstract
Introduction and Hypothesis: This report aims to prospectively describe the effectiveness and safety of injected cross-linked hyaluronic acid (HA) for the treatment of chronic vulvar fissures., Methods: A descriptive prospective case series design including 15 patients affected by chronic vulvar fissures who were treated with cross-linked HA filler between December 2020 and July 2021. The validated 21-item Vulvovaginal Symptoms Questionnaire (VSQ) was used to evaluate the results from baseline up to 9 months after the HA infiltration., Results: A total of 15 patients suffering from chronic vulvar fissures were treated with an injection of 19 mg/mL HA filler. We found a significant improvement in VSQ scores at the end of the treatment compared to baseline. Patients reported excellent tolerance of the procedure, and no complications were recorded., Conclusions: Cross-linked HA infiltration of the vulvar vestibule and posterior vaginal wall appeared to be a promising approach for chronic vulvar fissures., (© 2022. The International Urogynecological Association.)
- Published
- 2023
- Full Text
- View/download PDF
90. Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale.
- Author
-
Palacios S, Sánchez-Borrego R, Suárez Álvarez B, Lugo Salcedo F, González Calvo AJ, Quijano Martín JJ, Cancelo MJ, and Fasero M
- Subjects
- Female, Humans, Postmenopause, Vagina pathology, Quality of Life, Cross-Sectional Studies, Tamoxifen therapeutic use, Estrogens therapeutic use, Atrophy drug therapy, Atrophy pathology, Vulva pathology, Selective Estrogen Receptor Modulators therapeutic use, Dyspareunia pathology
- Abstract
Objective: To assess the correlation of different vulvovaginal atrophy therapeutic options with the quality of life of postmenopausal women., Study Design: The CRETA study is a descriptive, observational, cross-sectional, multicenter study designed to measure, besides treatment satisfaction and adherence, the quality of life of postmenopausal women diagnosed with vulvovaginal atrophy in 29 hospitals and centers across Spain., Main Outcome Measures: The study enrolled postmenopausal women currently receiving treatment with vaginal moisturizers, local estrogen therapy or ospemifene. Clinical features and treatment perceptions were collected by self-report questionnaire and quality of life was evaluated using the Cervantes scale., Results: Among the 752 women included, the ospemifene cohort showed a statistically significant lower global score (44.9 ± 21.7) on the Cervantes scale (and therefore, a better quality of life) than the cohorts treated with moisturizers (52.5 ± 21.6, p = 0.003) or local estrogen therapy (49.2 ± 23.8, p = 0.0473). In the analysis by domains, ospemifene-treated women showed statistically significant better scores in menopause & health and psychological status than moisturizers-treated women (p < 0.05). In the domains of sexuality and couple relations, the score for the quality of life of the ospemifene cohort was statistically significantly better than the scores in either of the cohorts treated with moisturizers (p < 0.001) or local estrogen therapy (p < 0.05)., Conclusions: Postmenopausal women diagnosed with vulvovaginal atrophy and treated with ospemifene have better quality of life than women treated with vaginal moisturizers or local estrogen therapy. The improvement observed with ospemifene is more remarkable in those aspects related to sex life and couple relations. CLINCIALTRIALS., Gov Number: NCT04607707., Competing Interests: Declaration of competing interest Shionogi S.L.U. sponsored the study and provided support for the medical writing assistance by Kalispera medical writing S.L. RS-B has received consulting fees and speaker's honoraria from Shionogi. SP has received consulting fees and speaker's honoraria from Shionogi and Bayer HC, Exeltis, Gedeon Richter, NovoNordisk, Procare H, Serelys, Lacer, Sandoz, Pfizer, Theramex. MJC has received consulting fees and speaker's honoraria from Shionogi. JGC and JJQM are currently working at Shionogi S.L.U. The other authors declare that they have no competing interest., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
91. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
- Author
-
Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-Méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-Campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-Capilla A, Sánchez-Borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, and Calaf J
- Subjects
- Female, Humans, Health Personnel, Societies, Scientific, Breast Neoplasms chemically induced, Estrogen Replacement Therapy adverse effects, Menopause
- Abstract
This project aims to develop eligibility criteria for menopausal hormone therapy (MHT). The tool should be similar to those already established for contraception A consortium of scientific societies coordinated by the Spanish Menopause Society met to formulate recommendations for the use of MHT by women with medical conditions based on the best available evidence. The project was developed in two phases. As a first step, we conducted 14 systematic reviews and 32 metanalyses on the safety of MHT (in nine areas: age, time of menopause onset, treatment duration, women with thrombotic risk, women with a personal history of cardiovascular disease, women with metabolic syndrome, women with gastrointestinal diseases, survivors of breast cancer or of other cancers, and women who smoke) and on the most relevant pharmacological interactions with MHT. These systematic reviews and metanalyses helped inform a structured process in which a panel of experts defined the eligibility criteria according to a specific framework, which facilitated the discussion and development process. To unify the proposal, the following eligibility criteria have been defined in accordance with the WHO international nomenclature for the different alternatives for MHT (category 1, no restriction on the use of MHT; category 2, the benefits outweigh the risks; category 3, the risks generally outweigh the benefits; category 4, MHT should not be used). Quality was classified as high, moderate, low or very low, based on several factors (including risk of bias, inaccuracy, inconsistency, lack of directionality and publication bias). When no direct evidence was identified, but plausibility, clinical experience or indirect evidence were available, "Expert opinion" was categorized. For the first time, a set of eligibility criteria, based on clinical evidence and developed according to the most rigorous methodological tools, has been defined. This will provide health professionals with a powerful decision-making tool that can be used to manage menopausal symptoms., Competing Interests: Declaration of competing interest In the past 3 years the following have received grant support from: Laura Baquedano: Organon, Theramex Joaquín Calaf: None declared Pluvio Coronado: MSD, Shionogi, Adventia, Procare, Abex Esther De la Viuda: Adamed, Bayer, Exeltis, Effik, Gedeon Ritcher, MSD, Organon, Procare Health Iberia, Sandoz, Shionogi, Teva, Theramex Plácido Llaneza: None declared Nicolás Mendoza: Astellas Pharma, Shionogi Verónica Nieto: None declared Borja Otero: Exeltis Spain Isabel María Ramírez: Exeltis, MSD, Pfizer Sonia Sánchez: Gynea-Kern, Shionogi, Theramex, Organon, Isdin, Lacer, Uriach, Dermolab Visitación Álvarez: None declared Leire Andraca: None declared Camil Castelo-Branco: Shionogi Europe Marta Correa: None declared José Luis Doval: Exeltis María Fasero: MSD, Organon, Theramex, Shionoghi Gabriel Fiol: MSD Ana Isabel Gómez: None declared María de los Ángeles Gómez: Theramex, Gedeon Richter y Exeltis Silvia González: Isdin, MSD, Shionogi, Lacer Misericordia Guinot: None declared Sonia Herrero: None declared Eva María Iglesias: Astellas Pharma, Shionoghi and Lacer Ana Rosa Jurado: Astellas Pharma, Bayer, Stada, Exeltis, Shionogi, MSD Iñaki Lete: Organon, Adamed España, Gedeon Ritcher Daniel María Lubián: Shionogi, Exeltis and Adamed Milagros Martínez: Shionoggi, Khern-Pharma Aníbal Nieto: None declared Laura Nieto: None declared Milagros Pedreira: None declared Ezequiel Pérez-Campos: Exeltis María Jesús Plá: None declared Jesús Presa: Theramex, Adamed Laboratorios, Kern Pharma Francisco Quereda: Theramex, Shionoghi, Lacer, Gedeon Richter, Amgen, MSD Miriam Ribes: Procareh Beatriz Roca: Organon Pablo Romero: None declared Antonio Sánchez: None declared Ana Santaballa: None declared Amparo Santamaría: None declared Iván Sola: None declared Francisco Tahones: None declared Zully Benítez: None declared Teresa Bombas: None declared María Jesús Cancelo: Shionogi Europe Antonio Cano: Astellas, Theramex and Italfarmaco Néstor C Garello: None declared Andrea R Genazzani: None declared Dimitrios G Goulis: None declared Luis R Hernández: None declared Santiago Palacios: Arkochim, Bayer Healthcare, Exeltis, Gedeon Richter, Novo Nordisk, Procare Health, Serelys, Mithra, Lacer, Sandoz Rafael Sánchez Borrego: Seid SA, Lacer SA, Shionogi Slu, Exeltis, Astellas Tommaso Simoncini: None declared, (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
92. The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain.
- Author
-
Arisi E, Bauer C, Farris M, Giulini-Limbach C, Glasier A, Lete I, May U, Mirjalili N, Nappi RE, Sanchez-Borrego R, and Serrano I
- Subjects
- Female, Humans, Spain, Contraceptives, Oral, Germany, Nonprescription Drugs, Surveys and Questionnaires, Italy, Progestins, Pharmacists
- Abstract
Purpose: To explore the perceived need and enthusiasm for over the counter (OTC) progestogen-only pills (POP)., Materials and Methods: A web-based survey of 1000 sexually active women (16-45) and 100 pharmacists in Germany, Italy and Spain., Results: Despite not wanting to conceive, 5-6% of women in each country were not using contraception and 8-20% were using methods less effective than condoms. At least 74% of respondents felt knowledgeable about the different contraceptives available but at least 1/3 had experienced difficulty accessing oral contraceptive (OCs) in the past two years. The cost of contraceptives, the need to see a doctor and long waits for appointments were cited as barriers for not using OCs. The majority agreed they would discuss with their doctor the decision to buy the POP, consult about side effects and other reproductive health issues. Over 2/3 of pharmacists in each country would be very, or fairly, likely to recommend the POP, agreeing that the benefits included improved access for women, and offered them more independence., Conclusions: Asked directly, women in Germany, Spain and Italy currently using contraception are positive about a POP OTC. Pharmacists are also positive, with the overwhelming majority in favour of providing POPs.
- Published
- 2022
- Full Text
- View/download PDF
93. Pulsed Magnetic Stimulation for Stress Urinary Incontinence and Its Impact on Sexuality and Health.
- Author
-
González-Isaza P, Sánchez-Borrego R, Lugo Salcedo F, Rodríguez N, Vélez Rizo D, Fusco I, and Callarelli S
- Subjects
- Humans, Female, Adolescent, Young Adult, Adult, Middle Aged, Aged, Aged, 80 and over, Quality of Life, Sexuality, Magnetic Phenomena, Treatment Outcome, Urinary Incontinence, Stress therapy, Urinary Incontinence
- Abstract
It is becoming increasingly common that patients' preferences move towards non-surgical approaches, such as pulsed magnetic stimulation, for female stress urinary incontinence., Objective: We evaluated the efficacy and safety of a device that uses electromagnetic technology to treat urinary incontinence, with an emphasis on health-related quality of life., Methods: A total of 47 female subjects from 18 to 80 years old were enrolled. After block randomization, treatment consisted of 2 pulsed planar magnetic stimulation sessions per week for 4 weeks (8 sessions). Validated questionnaires: Female Sexual Function Index, International Consultation on Incontinence Questionnaire for Urinary Incontinence: Short Form, and Pelvic Floor Bothersome. Follow-ups were performed at weeks 1, 9, and 14., Results: The present study is one of the first clinical trials published evaluating the efficacy and safety of the electromagnetism-based device with flat configuration in patients with stress urinary incontinence, showing a reduction in PFBQ, ICQSF, and Oxford test scores during follow-up, and significantly at week 14 of follow-up, which implied a favorable impact on clinical outcomes, quality of life, and sexuality., Conclusions: The improved results in the treatment group compared with the simulated group show that pulsed magnetic stimulation is a safe and attractive non-invasive alternative for patients who prefer non-surgical treatments.
- Published
- 2022
- Full Text
- View/download PDF
94. Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
- Author
-
Sánchez-Prieto M, Sánchez-Borrego R, Lubián-López DM, and Pérez-López FR
- Abstract
Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate. The risk/protective factors of ovarian cancer suggest that its etiology is multifactorial. Several factors are involved in age-related increases in carcinogenesis, including the accumulation of senescent cells, inflammaging (a chronic inflammatory state that persists in the elderly), and immunosenescence (aging of the immune system) changes associated with poor immune surveillance. At sites of inflammation, exposure to high levels of inflammatory mediators, such as reactive oxygen species, cytokines, prostaglandins, and growth factors, contributes to increased cell division and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the proinflammatory tumor microenvironment contributes to ovarian cancer metastasis and chemoresistance. This narrative review of the literature was carried out to delineate the possible role of inflammaging in the etiopathogenesis of ovarian cancer development. We discuss the current carcinogenic hypotheses, sites of origin, and etiological factors of ovarian cancer. Treatment of inflammation may represent an attractive strategy for both the prevention and therapy of ovarian cancer., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
95. Embracing the Nutritional Assessment in Cerebral Palsy: A Toolkit for Healthcare Professionals for Daily Practice.
- Author
-
Pinto C, Borrego R, Eiró-Gomes M, Casimiro I, Raposo A, Folha T, Virella D, and Moreira AC
- Subjects
- Caregivers, Child, Delivery of Health Care, Humans, Nutritional Status, Cerebral Palsy, Nutrition Assessment
- Abstract
Background: Nutritional status assessment (NSA) can be challenging in children with cerebral palsy (CP). There are high omission rates in national surveillance reports of weight and height information. Alternative methods are used to assess nutritional status that may be unknown to the healthcare professionals (HCP) who report these children. Caregivers experience challenges when dealing with feeding problems (FP) common in CP. Our aim was to assess the difficulties in NSA which are causing this underreport and to create solutions for registers and caregivers., Methods: An online questionnaire was created for registers. Three meetings with HCP and caregivers were held to discuss problems and solutions regarding NSA and intervention., Results: HCP mentioned difficulty in NSA due to a lack of time, collaboration with others, equipment, and childrens' motor impairment. Caregivers experienced difficulty in preparing nutritious meals with adapted textures. The creation of educational tools and other strategies were suggested. A toolkit for HCP was created with the weight and height assessment methods described and other for caregivers to deal with common FP., Conclusions: There are several difficulties experienced by HCP that might be overcome with educational tools, such as a toolkit. This will facilitate nutritional assessment and intervention and hopefully reduce underreporting.
- Published
- 2022
- Full Text
- View/download PDF
96. Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.
- Author
-
Barrett CD, Moore HB, Moore EE, Wang J, Hajizadeh N, Biffl WL, Lottenberg L, Patel PR, Truitt MS, McIntyre RC Jr, Bull TM, Ammons LA, Ghasabyan A, Chandler J, Douglas IS, Schmidt EP, Moore PK, Wright FL, Ramdeo R, Borrego R, Rueda M, Dhupa A, McCaul DS, Dandan T, Sarkar PK, Khan B, Sreevidya C, McDaniel C, Grossman Verner HM, Pearcy C, Anez-Bustillos L, Baedorf-Kassis EN, Jhunjhunwala R, Shaefi S, Capers K, Banner-Goodspeed V, Talmor DS, Sauaia A, and Yaffe MB
- Subjects
- Adolescent, Adult, Aged, COVID-19 blood, COVID-19 epidemiology, Cross-Sectional Studies, Female, Fibrinolytic Agents administration & dosage, Follow-Up Studies, Humans, Male, Middle Aged, Partial Thromboplastin Time, Respiratory Insufficiency blood, Respiratory Insufficiency etiology, Retrospective Studies, Thrombosis blood, Thrombosis drug therapy, Treatment Outcome, Young Adult, COVID-19 complications, Pandemics, Respiratory Insufficiency drug therapy, SARS-CoV-2, Thrombosis complications, Tissue Plasminogen Activator administration & dosage
- Abstract
Background: Pulmonary vascular microthrombi are a proposed mechanism of COVID-19 respiratory failure. We hypothesized that early administration of tissue plasminogen activator (tPA) followed by therapeutic heparin would improve pulmonary function in these patients., Research Question: Does tPA improve pulmonary function in severe COVID-19 respiratory failure, and is it safe?, Study Design and Methods: Adults with COVID-19-induced respiratory failure were randomized from May14, 2020 through March 3, 2021, in two phases. Phase 1 (n = 36) comprised a control group (standard-of-care treatment) vs a tPA bolus (50-mg tPA IV bolus followed by 7 days of heparin; goal activated partial thromboplastin time [aPTT], 60-80 s) group. Phase 2 (n = 14) comprised a control group vs a tPA drip (50-mg tPA IV bolus, followed by tPA drip 2 mg/h plus heparin 500 units/h over 24 h, then heparin to maintain aPTT of 60-80 s for 7 days) group. Patients were excluded from enrollment if they had not undergone a neurologic examination or cross-sectional brain imaging within the previous 4.5 h to rule out stroke and potential for hemorrhagic conversion. The primary outcome was Pao
2 to Fio2 ratio improvement from baseline at 48 h after randomization. Secondary outcomes included Pao2 to Fio2 ratio improvement of > 50% or Pao2 to Fio2 ratio of ≥ 200 at 48 h (composite outcome), ventilator-free days (VFD), and mortality., Results: Fifty patients were randomized: 17 in the control group and 19 in the tPA bolus group in phase 1 and eight in the control group and six in the tPA drip group in phase 2. No severe bleeding events occurred. In the tPA bolus group, the Pao2 to Fio2 ratio values were significantly (P < .017) higher than baseline at 6 through 168 h after randomization; the control group showed no significant improvements. Among patients receiving a tPA bolus, the percent change of Pao2 to Fio2 ratio at 48 h (16.9% control [interquartile range (IQR), -8.3% to 36.8%] vs 29.8% tPA bolus [IQR, 4.5%-88.7%]; P = .11), the composite outcome (11.8% vs 47.4%; P = .03), VFD (0.0 [IQR, 0.0-9.0] vs 12.0 [IQR, 0.0-19.0]; P = .11), and in-hospital mortality (41.2% vs 21.1%; P = .19) did not reach statistically significant differences when compared with those of control participants. The patients who received a tPA drip did not experience benefit., Interpretation: The combination of tPA bolus plus heparin is safe in severe COVID-19 respiratory failure. A phase 3 study is warranted given the improvements in oxygenation and promising observations in VFD and mortality., Trial Registry: ClinicalTrials.gov; No.: NCT04357730; URL: www., Clinicaltrials: gov., (Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
97. Sintra Grows Healthy: development and implementation of a food literacy curriculum for primary schools.
- Author
-
Nogueira T, Ferreira RJ, Sócrates M, Dias da Silva V, Liñan Pinto M, Borrego R, and Sousa J
- Abstract
Objective: Describe the process of development and implementation of Health at the Table - a food literacy curriculum for primary school aged children., Design: Through a community-based research process, Health at the Table development and implementation took place in four stages: exploratory study, production, implementation and monitoring., Setting: Primary schools of Sintra's municipality, Portugal., Participants: Children (6-10 years), teachers, school staff and children's legal guardians of three primary schools during the pilot project and eight primary schools in the second year., Results: During the needs assessment phase, 99·1 % (n 341) of the children's legal guardians, 100 % (n 34) of the teachers and 100 % (n 19) of the school staff considered that the school plays an important or very important role in children's food literacy (stage 1). During the pilot project, a manual with sixty session plans was developed (stage 2). In the second year, Health at the Table was implemented by seventy-two trained teachers during one school year (stage 3). Most of the teachers agreed that the curriculum was appropriate (69·2 %) and that children developed health, wellness/well-being and environmental skills (83·1 %). Most of the children said they had learned about healthy eating (86·3 %) and claimed to eat healthier since the Health at the Table implementation (58·9 %) (stage 4)., Conclusions: Health at the Table is a food literacy curriculum that can be reproduced in similar contexts in a sustainable way. The need to combine educational strategies with a healthy school food environment is reinforced to increase effectiveness in tackling childhood obesity.
- Published
- 2022
- Full Text
- View/download PDF
98. Eastern Association for the Surgery of Trauma Multicenter Trial: Comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients.
- Author
-
Yorkgitis BK, Tatum DM, Taghavi S, Schroeppel TJ, Noorbakhsh MR, Philps FH, Bugaev N, Mukherjee K, Bellora M, Ong AW, Ratnasekera A, Nordham KD, Carrick MM, Haan JM, Lightwine KL, Lottenberg L, Borrego R, Cullinane DC, Berne JD, Rodriguez Mederos D, Hayward TZ 3rd, Kerwin AJ, and Crandall M
- Subjects
- Aged, Aspirin adverse effects, Aspirin therapeutic use, Cardiovascular Diseases drug therapy, Cardiovascular Diseases epidemiology, Comorbidity, Factor Xa Inhibitors adverse effects, Factor Xa Inhibitors therapeutic use, Female, Hospital Mortality, Humans, Male, Risk Assessment methods, Risk Assessment statistics & numerical data, Trauma Severity Indices, Treatment Outcome, United States epidemiology, Warfarin adverse effects, Warfarin therapeutic use, Anticoagulant Reversal Agents administration & dosage, Brain Injuries, Traumatic complications, Brain Injuries, Traumatic diagnosis, Brain Injuries, Traumatic mortality, Brain Injuries, Traumatic therapy, Deamino Arginine Vasopressin administration & dosage, Fibrinolytic Agents adverse effects, Fibrinolytic Agents classification, Fibrinolytic Agents therapeutic use, Hemorrhage etiology, Hemorrhage mortality, Hemorrhage therapy, Platelet Transfusion statistics & numerical data
- Abstract
Background: Trauma teams are often faced with patients on antithrombotic (AT) drugs, which is challenging when bleeding occurs. We sought to compare the effects of different AT medications on head injury severity and hypothesized that AT reversal would not improve mortality in severe traumatic brain injury (TBI) patients., Methods: An Eastern Association for the Surgery of Trauma-sponsored prospective, multicentered, observational study of 15 trauma centers was performed. Patient demographics, injury burden, comorbidities, AT agents, and reversal attempts were collected. Outcomes of interest were head injury severity and in-hospital mortality., Results: Analysis was performed on 2,793 patients. The majority of patients were on aspirin (acetylsalicylic acid [ASA], 46.1%). Patients on a platelet chemoreceptor blocker (P2Y12) had the highest mean Injury Severity Score (9.1 ± 8.1). Patients taking P2Y12 inhibitors ± ASA, and ASA-warfarin had the highest head Abbreviated Injury Scale (AIS) mean (1.2 ± 1.6). On risk-adjusted analysis, warfarin-ASA was associated with a higher head AIS (odds ratio [OR], 2.43; 95% confidence interval [CI], 1.34-4.42) after controlling for Injury Severity Score, Charlson Comorbidity Index, initial Glasgow Coma Scale score, and initial systolic blood pressure. Among patients with severe TBI (head AIS score, ≥3) on antiplatelet therapy, reversal with desmopressin (DDAVP) and/or platelet transfusion did not improve survival (82.9% reversal vs. 90.4% none, p = 0.30). In severe TBI patients taking Xa inhibitors who received prothrombin complex concentrate, survival was not improved (84.6% reversal vs. 84.6% none, p = 0.68). With risk adjustment as described previously, mortality was not improved with reversal attempts (antiplatelet agents: OR 0.83; 85% CI, 0.12-5.9 [p = 0.85]; Xa inhibitors: OR, 0.76; 95% CI, 0.12-4.64; p = 0.77)., Conclusion: Reversal attempts appear to confer no mortality benefit in severe TBI patients on antiplatelet agents or Xa inhibitors. Combination therapy was associated with severity of head injury among patients taking preinjury AT therapy, with ASA-warfarin possessing the greatest risk., Level of Evidence: Prognostic, level II., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
99. A strong handshake! Do not forget to measure grip strength in menopause: a simple way to predict general frailty/impairment.
- Author
-
Sánchez-Borrego R
- Subjects
- Aged, Female, Geriatric Assessment, Hand Strength, Humans, Menopause, Frailty diagnosis
- Abstract
Competing Interests: Financial disclosure/conflicts of interest: None reported.
- Published
- 2021
- Full Text
- View/download PDF
100. Sexual Dysfunction in Postmenopausal Women with Breast Cancer on Adjuvant Aromatase Inhibitor Therapy.
- Author
-
Lubián López DM, Butrón Hinojo CA, Sánchez-Prieto M, Mendoza N, and Sánchez-Borrego R
- Abstract
Introduction: The aim of this study was to investigate whether postmenopausal women with breast cancer (BC) on adjuvant aromatase inhibitor (AI) therapy have a higher prevalence of female sexual dysfunction (FSD). Second, the aim was to determine the quality of life (QoL) and level of anxiety depending on whether or not they are AI users., Methods: A prospective cross-sectional study involving 168 patients was performed. Three questionnaires were carried out: sexual functioning was evaluated with the Female Sexual Function Index (FSFI), while the EORTC QLQ-BR23 measures to study QoL in patients with BC and the State-Trait Anxiety Inventory (STAI) questionnaire (trait and status) were used to assess anxiety status in patients under treatment with AIs or not., Results: 47.6% (80/168) of the postmenopausal BC survivors were not sexually active (mean time after surgery: 48.6 months) despite a relatively low mean age (56.43 years). Postmenopausal AI-treated women had significantly worse sexual function as measured by the FSFI (23.40 ± 5.26 vs. 30.16 ± 2.24; p = 0.000). There were significant differences between both groups in all domains, except orgasm. The QoL score was 37.67 ± 7.38 in AI users versus 39.00 ± 1.44 among nonusers ( p = 0.053). Patients under endocrine treatment also presented STAI scores significantly higher (25.83 ± 4.99 vs. 19.00 ± 7.12; p = 0.000). Trait anxiety was high in both groups, but this was not statistically significant., Conclusions: We observed a high prevalence of sexual inactivity among BC survivors regardless of AI use. Patients with AI use presented significantly higher prevalence of FSD, worse QoL, and greater anxiety., Competing Interests: The authors did not report any potential conflicts of interest., (Copyright © 2020 by S. Karger AG, Basel.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.